EveryONE Medicines is committed to developing individualized precision medicines targeting genetic variants causing fatal, neurodegenerative diseases unique to just a few or even ONE patient. Momentum is building as technological advances with genomic testing and the prevalence of testing is improving rapidly to identify the rarest of rare mutations. Through a collaborative effort across all stakeholders in the treatment and diagnosis of rare genetic disease, EveryONE Medicines will bring a scalable solution to meet the needs of the individual patient who currently has limited hope.

Biotechnology

Health Care

Health Diagnostics

EveryONE Medicines

EveryONE Medicines' headquarters in Boston, United States

Kent Rogers

Michelle Mellion

Nessan Bermingham

Nicole P. Ouellette

Deb Gouveia

Srinivas Chunduru

Andrew Roddam

Description

People (7)

Kent Rogers

Srinivas Chunduru

Deb Gouveia

Barbara Douglas

Julia Vitarello

Nessan Bermingham

Joshua Ofman M.D.

Jobs